Does IRBESARTAN Cause Hyponatraemia? 485 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 485 reports of Hyponatraemia have been filed in association with IRBESARTAN (Irbesartan). This represents 4.8% of all adverse event reports for IRBESARTAN.
485
Reports of Hyponatraemia with IRBESARTAN
4.8%
of all IRBESARTAN reports
4
Deaths
461
Hospitalizations
How Dangerous Is Hyponatraemia From IRBESARTAN?
Of the 485 reports, 4 (0.8%) resulted in death, 461 (95.1%) required hospitalization, and 8 (1.6%) were considered life-threatening.
Is Hyponatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 485 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
Cough (438)
What Other Drugs Cause Hyponatraemia?
FUROSEMIDE (3,127)
HYDROCHLOROTHIAZIDE (2,138)
OMEPRAZOLE (1,635)
LANSOPRAZOLE (1,416)
SERTRALINE (1,332)
RAMIPRIL (1,178)
SPIRONOLACTONE (1,166)
PANTOPRAZOLE (1,134)
INDAPAMIDE (976)
AMLODIPINE (879)
Which IRBESARTAN Alternatives Have Lower Hyponatraemia Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE